by Jordana Choucair | Jun 1, 2022 | Payers
Moody’s Investors Service released a report showing that strong enrollment growth in Medicare Advantage and Medicaid helped insurers have a solid first quarter. According to the report, the average growth in earnings before interest, taxes, depreciation, and...
by Jordana Choucair | Jun 1, 2022 | Providers
Kaufman Hall’s latest National Hospital Flash Report indicates that hospitals and health systems suffered their fourth straight month of negative operating margins in April. The median operating margin index for hospitals and health systems in April was -3.09 percent,...
by Jordana Choucair | Jun 1, 2022 | Public Health/Prevention
The House Judiciary Committee announced it will markup a gun control package on Thursday. The “Protecting Our Kids Act” includes proposals that would raise the age limit to purchase some semi-automatic rifles to 21 years old, establish a federal ban on new...
by Jordana Choucair | May 31, 2022 | Life Sciences
Next week a key Food and Drug Administration (FDA) advisory committee will examine Novavax’s application for an emergency use authorization for its COVID-19 vaccine for adults 18 and older. Novavax originally planned to ask FDA for authorization by May 2021 but...
by Jordana Choucair | May 31, 2022 | Life Sciences
British drugmaker GSK PLC will buy vaccine manufacturer Affinivax Inc. for up to $3.3 billion, giving it access to promising experimental vaccine technology that targets two dozen common diseases. A GSK executive said Affinivax’s technology could broaden...
by Jordana Choucair | May 31, 2022 | Payers
Health and Human Services (HHS) Secretary Xavier Becerra announced on Friday that the Centers for Medicare & Medicaid Services (CMS) will not lower Medicare premiums for adults 65 and over until 2023. The adjustment is intended to compensate for...
Recent Comments